ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Altamira Therapeutics Ltd

Altamira Therapeutics Ltd (CYTO)

0.30
0.00
( 0.00% )
Updated: 19:00:00

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2014
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 0
Operating Income -5.86M
Pre Tax Income -5.86M
Net Income -5.86M
Preferred Dividends 0
Basic Earnings Per Share (EPS) 0
EBIT -5.86M
EBITDA -5.84M
Year End December 30 2023 20162017201820192020202120222023
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 0000064k306k158k
Operating Income -30.22M-25.39M-11.47M-7.26M-5.5M-17.1M-26.13M-7.73M
Pre Tax Income -30.79M-24.43M-11.33M-6.83M-8.22M-17.37M-26.54M-3.97M
Net Income -30.66M-24.41M-11.5M-6.63M-8.2M-17.39M-26.53M-3.87M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.578-0.364-0.112-0.093-0.104-0.259-0.395-0.056
EBIT -30.22M-25.39M-11.47M-7.26M-5.5M-17.1M-26.13M-2.53M
EBITDA -30.13M-25.27M-11.4M-7.23M-5.48M-15.49M-13.54M-7.61M

Your Recent History

Delayed Upgrade Clock